AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2693-7247/011
SV Anichkov Department of Neuropharmacology, FSBSI Institute of Experimental Medicine, St. Petersburg, Russia
*Corresponding Author: Irina V Okunevich, PhD (Pharmacology), Senior Researcher, SV Anichkov Department of Neuropharmacology of FSBSI, Federal State Budgetary Scientific Institution Institute of Experimental Medicine (IEM), 12 Acad. Pavlov St., 197376 St. Petersburg, Russia.
Citation: Irina V Okunevich (2021) Short report of original clinical trial of neurotropic drug: L-dopa efficiency-cy of using in therapy of coronary artery disease, J Pharmaceutics and Pharmacology Research 4(1); DOI: 10.31579/2693-7247/011
Copyright: © 2021, Irina V Okunevich, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 22 August 2020 | Accepted: 14 September 2020 | Published: 27 February 2021
Keywords: coronary artery disease; atherosclerosis; dyslipidemia; complex therapy; LEVOPA
The short clinical study is devoted to the corrective action of the neurotropic drug LEVOPA (L-DOPA) in patients with coronary artery disease (CAD) complicated by atherogenic dyslipidemia (DLP), moderate angina pectoris (AP), arterial hypertension (AH) and other risk factors for the development of atherosclerosis (AS). Purposefully in neurology, drug of L-DOPA - LEVOPA is used in significant doses (3-10 g/day) to treat Parkinson's disease, including atherosclerotic genesis. In this study, the neurotropic drug LEVOPA was used as an active metabolic agent in the complex therapy of CAD in a small dose of 0.5 g 3 times a day, with chronic oral administration for 4 weeks. As a result, an improvement in the lipid profile of blood and the hypolipidemic property of the drug LEVOPA were found. An improvement in hemodynamics and general well-being was noted in treated patients with aggravating risk factors for the development of AS. We had notice the decrease of lipid peroxidation (LPO) too.
Lipid-lowering therapy is currently widely used in programs for the primary and secondary prevention of cardiovascular events caused by atherosclerosis (AS), including in ischemic (coronary) heart disease (CAD) due to the high prevalence and mortality [1-4]. AS, arterial hypertension (AH), diabetes mellitus (DM) and obesity (Ob) are “metabolic pandemics” of the 21st century, requiring correction from the standpoint of improving diagnostics and adequate treatment. In patients with CAD aggravated by atherogenic dyslipidemia (DLP) with an improvement in the blood lipid spectrum, the incidence of myocardial infarction (MI) decreases. According to Russian recommendations [5], the goal of complex therapy for CAD associated with AH and atherogenic DLP is to achieve a blood pressure value (<130>
L-DOPA, a precursor of dopamine synthesis, belongs to physiologically active substances with a nonspecific positive effect on metabolism. Usually, the drug L-DOPA - LEVOPA is used in significant doses (3-10 g per day) for the treatment of Parkinson's disease, including atherosclerotic genesis [7].
Earlier in joint experimental clinical research with employees of the State Medical University named after IP Pavlov (St. Petersburg, Russia) found that L-DOPA stimulates reparative processes, restores the activity of the sympathetic-adrenal system, and reduces the degree of LPO progression. Under the influence of L-DOPA in patients after myocardial infarction (MI), he-modynamic parameters and the clinical course of CAD improve (patentable closed researches). Based on long term studies, a hypothesis was put forward about the possible correction in lipid metabolism disorders with the help of the inclusion of the drug L-DOPA in the complex therapy in patients of AS complicated DLP.
Purpose of the clinical study
The aim of this investigation was to evaluate the effectiveness in complex therapy of the neurotropic drug LEVOPA in CAD patients with DLP and other risk factors of AS.
Object of the study
60 patients with CAD (men, mean age 60.2 ± 5.4 years) with moderate AP I-II degree according to NYHA classification were examined. The reason for hospitalization of patients with CAD was pain syndrome and attacks of AP (3-5 times a day). Upon admission to the clinic, the baseline values of the blood serum lipid spectrum were analyzed for the presence of DLP (phenotyping according to Fredrickson). The assessment of the patient's condition before the start of therapy and after 4 weeks of treatment was carried out according to the results of electrocardiographic, biochemical studies and general well-being. 17 out of 60 CAD patients did not have the significant lipid metabolism disorders. The selected cohort in 43 patients was complex in terms of the number of comorbidities.
In an open, comparative, placebo uncontrolled study of 60 patients, 43 men were selected with chronic CAD, aggravated by DLP II and IV phenotypes, AH and other associated risk factors for the development of AS. Due to the high risk of developing AS, in this sample of patients, the target values of the blood spectrum were tightened: total cholesterol <4>0.95 mM/l, LDL cholesterol <1>
The exclusion criteria from this study were acute MI, chronic cardiac insufficiency with an ejection fraction below 40%, severe AH (>170-180 mm Hg), as well as chronic diseases of the liver, biliary tract, kidney, hypo- and hyper function of the thyroid gland.
Patient`s treatment regimen
All 43 patients with CAD and DLP received basic therapy: antithrombotic agents (aspirin cardio), long-acting nitrates (nitrosorbide, isosorbide dinitrate), antihypertensive drugs (ACE inhibitors), in the presence of myocardial ischemia - alpha-blockers (metoprolol, carvedilol) in individual doses. A cohort of 43 patients was divided into 2 groups: one group of 20 people (group 2) was prescribed basic CAD therapy for 4 weeks, and patients of group 3 of 23 people were given complex treatment: basic therapy + L-DOPA ( LEVOPA) 0.5 g 3 times a day for 4 weeks too. For comparison, as a control (group 1), we used the data of laboratory analyzes of 10 apparently healthy men without DLP (55-65 years old).
The Biochemical analysis
The blood levels of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were studied by standardized biochemical research methods and in comparison with internal standards of human serum (USA) by analyzer Technicon AA-II (USA). The cholesterol index of atherogenity (IA) was calculated according to the common formula after academician A.N. Klimov (IEM, Russia): [(TC – HDL-C) / HDL-C]. In blood we analyzed with standard generally accepted methods, spectrophotometrically by the analyzer the levels of hormone corticosterone (CS), non-esterified fatty acids (NEFA), glucose (G), the content of diene conjugates (DC), malonic di-aldehyde (MDA) as products of LPO.
The results of biochemical studies have shown the following. In the analysis of venous blood of patients with CAD, hyperglycemia initially on an empty stomach was 8.0 mM/l. By the end of the study, there was a 13-27
Should be emphasized, in the short report about the presented clinical study, performed on a small cohort of 43 patients was and remains the only and original one. Until now there are no similar studies with using L-DOPA found.
The drug L-DOPA, which in experimental and preliminary clinical research has a pronounced lipid-lowering effect and anti-ischemic action, was used with positive results in a clinical set-ting as a metabolic drug in patients with CAD in the complex treatment of low doses - 0.5 g 3 times per day for 4 weeks. It is important to point out that in this small cohort of patients with CAD, burdened mainly by DLP and AH, it was possible to achieve a significant correction of biochemical indicators of homeostasis and improve the quality of life of patients.
Patients with comorbid pathology were discharged from the clinic 3-5 days earlier than usual with good well-being.
By the end of the study, patients receiving additional LEVOPA lost an average of 1.7 kilo-grams. This fact is positive, but was not the goal of presented clinical study and in the future would need additional verification.
Thus, as a result of complex therapy with the use of the drug LEVOPA for 4 weeks contributed to improvement in the lipid spectrum of blood.
It was observed accompanying decrease in the levels of G, NEFA and hormone CS were observed with normalization of the values of the studied substrates and increased stress resistance.
The positive effect of the course of treatment with LEVOPA was combined without any side effects from liver and other organs which assessed only visually, but not in details.
The manifestation of the effectiveness of L-DOPA can be explained by the preliminary good preparation of patients for investigation, use of a cholesterol-lowering diet and by the higher sensitivity to drug therapy despite the aggravating factors of residential patients (elderly men). It is possible that the beneficial curative effect was influenced by the ability of L-DOPA to reduce the activity of sympathoadrenal system.
As the main conclusion, L-DOPA can be considered is really active metabolic agent with its own original complex action for the correction of socially significant comorbid diseases.
Inspired by the result, we believe more research is needed and we look forward to further clinical studies and more extensive research will allow us to more deeply assess the multifaceted properties of L-DOPA.
The clinic investigation was carried out with humanity and approved by Ethics Committee of the State Medical University named after IP Pavlov. All the patients had informed consent.
In memory of the joint clinical work, I express my gratitude to Professor K.V. Temirova and associate professor of the department Kurlygina L.A. - qualified doctors and excellent people.
There is no conflict of interest.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
